[go: up one dir, main page]

AU1154992A - Use of substituted polysaccharides for the treatment of degenerative articular ailments - Google Patents

Use of substituted polysaccharides for the treatment of degenerative articular ailments

Info

Publication number
AU1154992A
AU1154992A AU11549/92A AU1154992A AU1154992A AU 1154992 A AU1154992 A AU 1154992A AU 11549/92 A AU11549/92 A AU 11549/92A AU 1154992 A AU1154992 A AU 1154992A AU 1154992 A AU1154992 A AU 1154992A
Authority
AU
Australia
Prior art keywords
ailments
treatment
substituted polysaccharides
degenerative articular
articular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU11549/92A
Inventor
Ruth Raiss
Matthias Wiesner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU1154992A publication Critical patent/AU1154992A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU11549/92A 1991-01-30 1992-01-15 Use of substituted polysaccharides for the treatment of degenerative articular ailments Withdrawn AU1154992A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4102674 1991-01-30
DE4102672 1991-01-30
DE4102672 1991-01-30
DE4102674 1991-01-30

Publications (1)

Publication Number Publication Date
AU1154992A true AU1154992A (en) 1992-09-07

Family

ID=25900612

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11549/92A Withdrawn AU1154992A (en) 1991-01-30 1992-01-15 Use of substituted polysaccharides for the treatment of degenerative articular ailments

Country Status (2)

Country Link
AU (1) AU1154992A (en)
WO (1) WO1992013541A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668963B2 (en) * 1992-07-30 1996-05-23 Seikagaku Kogyo Kabushiki Kaisha Antirheumatic composition

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459257A (en) * 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
ES2241063T3 (en) * 1996-12-13 2005-10-16 Lescarden, Inc. TREATMENT OF OSTEOARTHRITIS THROUGH THE ADMINISTRATION OF POLI-N-ACETIL-D-GLUCOSAMINE.
US5902800A (en) * 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders
DE10053053A1 (en) * 2000-10-19 2002-05-16 Knoell Hans Forschung Ev Pharmaceutical formulations for the inhibition of inflammatory arthritis
FR2864089B1 (en) * 2003-12-19 2006-02-03 Aventis Pharma Sa CHONDROID SULFATE CARBOXY-REDUCED DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICINE AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
FR2864087B1 (en) * 2003-12-19 2006-01-27 Aventis Pharma Sa DERMATAN SULFATE CARBOXY-REDUCED DERIVATIVES, THEIR PREPARATION, THEIR MEDICINAL APPLICATION AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
FR2864090B1 (en) * 2003-12-19 2006-01-27 Aventis Pharma Sa CARBOXY-REDUCED HYALURONIC ACID DERIVATIVES, THEIR PREPARATION, THEIR USE AS A MEDICINAL PRODUCT AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
ES2251289B1 (en) 2004-02-27 2007-07-01 Bioiberica, S.A. NEW THERAPEUTIC USE OF A GROUP OF SULFATED POLYSACARIDS.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS48973A (en) * 1971-05-28 1973-01-09
US4066829A (en) * 1976-07-12 1978-01-03 American Cyanamid Company Malto-dextrin poly(H-)sulfates
FR2584606A1 (en) * 1985-07-12 1987-01-16 Dropic USE OF POLY- AND OLIGOSACCHARIDES FOR THE PRODUCTION OF ACTIVE MEDICAMENTS IN THE PATHOLOGIES OF CONNECTIVE TISSUE
WO1988007060A1 (en) * 1987-03-19 1988-09-22 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
DE3921761A1 (en) * 1989-07-01 1991-01-03 Hoechst Ag SUBSTITUTED POLYSACCHARIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE PROPHYLAXIS AND THE TREATMENT OF VIRUS DISEASES

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668963B2 (en) * 1992-07-30 1996-05-23 Seikagaku Kogyo Kabushiki Kaisha Antirheumatic composition

Also Published As

Publication number Publication date
WO1992013541A1 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
AU5969490A (en) Steerable intramedullary fracture reduction device
AU6209394A (en) The use of bisphosphonates in bone surgery
AU1935192A (en) Spinal orthosis
AU2748892A (en) Surgical apparatus
AU7545594A (en) Implantable device for the treatment of aedemas
AU2223192A (en) Patella prostheses
IL121170A0 (en) Compositions for the treatment of dermatological disorders
AU1783292A (en) Medical/surgical devices
AU4944093A (en) Osteosynthesis aid
AU7205894A (en) Purified natural and synthetic compounds for the treatment of osteoarthritis
AU618231B3 (en) Treatment of emulsions
HUP9802861A3 (en) Use of calendula glycosides for the treatment of psoriasis
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU6253094A (en) Methods for the treatment of osteoporosis
AU3236093A (en) The use of ob-101 to treat inflammation
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU3235693A (en) The use of ob-104 to treat inflammation
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU1252592A (en) Swallowable pharmaceutical compositions
AU2806692A (en) Medicament for the treatment of anxiety
AU1154992A (en) Use of substituted polysaccharides for the treatment of degenerative articular ailments
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
HUP9802077A3 (en) Use of alendronate for preparing medicament useful for lessening the risk of vertebral fractures
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU3027692A (en) Compositions for the treatment of mammalian diseases